The Effects of Cilnidipine on Metabolic Syndrome Improvement

Clinical trial NCT00325936 · COMPLETED

Trial details

NCT number: NCT00325936
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Metabolic Syndrome X

Start date: 2005-07-01
Primary completion: 2007-06-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.